Ocean Biomedical, Inc. (NASDAQ:OCEAW) Short Interest Update

Ocean Biomedical, Inc. (NASDAQ:OCEAW) saw a large decline in short interest in the month of March. As of March 15th, there was short interest totalling 4,000 shares, a decline of 42.0% from the February 28th total of 6,900 shares. Based on an average daily trading volume, of 58,100 shares, the short-interest ratio is currently 0.1 days.

Ocean Biomedical Stock Down 8.7 %

Shares of OCEAW opened at $0.02 on Friday. Ocean Biomedical has a twelve month low of $0.02 and a twelve month high of $0.36. The firm’s 50 day moving average price is $0.03 and its two-hundred day moving average price is $0.03.

About Ocean Biomedical

Ocean Biomedical, Inc, a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.